Hyperbaric oxygen therapy and neurologic disease: the time has come.
Mychaskiw
George
G
D018685:Anesthetics, Inhalation / Q000009:adverse effects; D000818:Animals; D001321:Autistic Disorder / Q000139:chemically induced / Q000628:therapy*; D006801:Humans; D006931:Hyperbaric Oxygenation; D008738:Methyl Ethers / Q000009:adverse effects; D009316:National Institutes of Health (U.S.); D012109:Research Support as Topic; D000077149:Sevoflurane; D014481:United States
D018685:Anesthetics, Inhalation; D008738:Methyl Ethers; D000077149:Sevoflurane